InMed Pharmaceuticals Competitors

(DDXS) (OTCMKTS:DDXS) and InMed Pharmaceuticals (OTCMKTS:IMLFF) are both health technology companies, but which is the better investment? We will contrast the two companies based on the strength of their valuation, analyst recommendations, dividends, risk, profitability, institutional ownership and earnings.

Analyst Recommendations

This is a summary of current ratings and recommmendations for (DDXS) and InMed Pharmaceuticals, as reported by MarketBeat.

Earnings & Valuation

This table compares (DDXS) and InMed Pharmaceuticals' gross revenue, earnings per share and valuation.

Profitability

This table compares (DDXS) and InMed Pharmaceuticals' net margins, return on equity and return on assets.

(TNGN) (OTCMKTS:TNGN) and InMed Pharmaceuticals (OTCMKTS:IMLFF) are both health technology companies, but which is the better investment? We will contrast the two companies based on the strength of their valuation, analyst recommendations, dividends, risk, profitability, institutional ownership and earnings.

Analyst Recommendations

This is a summary of current ratings and recommmendations for (TNGN) and InMed Pharmaceuticals, as reported by MarketBeat.

Earnings & Valuation

This table compares (TNGN) and InMed Pharmaceuticals' gross revenue, earnings per share and valuation.

Profitability

This table compares (TNGN) and InMed Pharmaceuticals' net margins, return on equity and return on assets.

Abattis Bioceuticals (OTCMKTS:ATTBF) and InMed Pharmaceuticals (OTCMKTS:IMLFF) are both medical companies, but which is the better investment? We will contrast the two companies based on the strength of their valuation, analyst recommendations, dividends, risk, profitability, institutional ownership and earnings.

Analyst Recommendations

This is a summary of current ratings and recommmendations for Abattis Bioceuticals and InMed Pharmaceuticals, as reported by MarketBeat.

Earnings & Valuation

This table compares Abattis Bioceuticals and InMed Pharmaceuticals' gross revenue, earnings per share and valuation.

Profitability

This table compares Abattis Bioceuticals and InMed Pharmaceuticals' net margins, return on equity and return on assets.

ADiTx Therapeutics (NASDAQ:ADTX) and InMed Pharmaceuticals (OTCMKTS:IMLFF) are both medical companies, but which is the better investment? We will contrast the two companies based on the strength of their valuation, analyst recommendations, dividends, risk, profitability, institutional ownership and earnings.

Analyst Recommendations

This is a summary of current ratings and recommmendations for ADiTx Therapeutics and InMed Pharmaceuticals, as reported by MarketBeat.

Profitability

This table compares ADiTx Therapeutics and InMed Pharmaceuticals' net margins, return on equity and return on assets.

Earnings & Valuation

This table compares ADiTx Therapeutics and InMed Pharmaceuticals' gross revenue, earnings per share and valuation.

Summary

ADiTx Therapeutics beats InMed Pharmaceuticals on 1 of the 1 factors compared between the two stocks.

InMed Pharmaceuticals (OTCMKTS:IMLFF) and Algernon Pharmaceuticals (OTCMKTS:AGNPF) are both health technology companies, but which is the superior business? We will contrast the two companies based on the strength of their dividends, profitability, earnings, analyst recommendations, institutional ownership, risk and valuation.

Analyst Ratings

This is a summary of recent recommendations for InMed Pharmaceuticals and Algernon Pharmaceuticals, as provided by MarketBeat.com.

Profitability

This table compares InMed Pharmaceuticals and Algernon Pharmaceuticals' net margins, return on equity and return on assets.

Earnings and Valuation

This table compares InMed Pharmaceuticals and Algernon Pharmaceuticals' revenue, earnings per share (EPS) and valuation.

InMed Pharmaceuticals (OTCMKTS:IMLFF) and Almirall (OTCMKTS:LBTSF) are both health technology companies, but which is the superior business? We will contrast the two companies based on the strength of their dividends, profitability, earnings, analyst recommendations, institutional ownership, risk and valuation.

Analyst Ratings

This is a summary of recent recommendations for InMed Pharmaceuticals and Almirall, as provided by MarketBeat.com.

Profitability

This table compares InMed Pharmaceuticals and Almirall's net margins, return on equity and return on assets.

Earnings and Valuation

This table compares InMed Pharmaceuticals and Almirall's revenue, earnings per share (EPS) and valuation.

Summary

Almirall beats InMed Pharmaceuticals on 1 of the 1 factors compared between the two stocks.